-
1
-
-
0036782278
-
VEGF and the quest for tumour angiogenesis factors
-
Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2 (2002) 795-803
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 795-803
-
-
Ferrara, N.1
-
2
-
-
85013312416
-
Tumor angiogenesis: therapeutic implications
-
Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 285 (1971) 1182-1186
-
(1971)
N Engl J Med
, vol.285
, pp. 1182-1186
-
-
Folkman, J.1
-
3
-
-
0025141337
-
What is the evidence that tumors are angiogenesis dependent?
-
Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82 (1990) 4-6
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 4-6
-
-
Folkman, J.1
-
4
-
-
0034648765
-
Angiogenesis in cancer and other diseases
-
Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
-
(2000)
Nature
, vol.407
, pp. 249-257
-
-
Carmeliet, P.1
Jain, R.K.2
-
5
-
-
0030498734
-
Angiogenesis and metastasis
-
Ellis L.M., and Fidler I.J. Angiogenesis and metastasis. Eur J Cancer 32A (1996) 2451-2460
-
(1996)
Eur J Cancer
, vol.32 A
, pp. 2451-2460
-
-
Ellis, L.M.1
Fidler, I.J.2
-
6
-
-
0026027556
-
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation
-
Liotta L.A., Steeg P.S., and Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 (1991) 327-336
-
(1991)
Cell
, vol.64
, pp. 327-336
-
-
Liotta, L.A.1
Steeg, P.S.2
Stetler-Stevenson, W.G.3
-
7
-
-
1542319129
-
Cancer without disease
-
Folkman J., and Kalluri R. Cancer without disease. Nature 427 (2004) 787
-
(2004)
Nature
, vol.427
, pp. 787
-
-
Folkman, J.1
Kalluri, R.2
-
8
-
-
0031469819
-
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
-
Boehm T., Folkman J., Browder T., and O'Reilly M.S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390 (1997) 404-407
-
(1997)
Nature
, vol.390
, pp. 404-407
-
-
Boehm, T.1
Folkman, J.2
Browder, T.3
O'Reilly, M.S.4
-
9
-
-
0028153751
-
Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma
-
Modzelewski R.A., Davies P., Watkins S.C., Auerbach R., Chang M.J., and Johnson C.S. Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma. Cancer Res 54 (1994) 336-339
-
(1994)
Cancer Res
, vol.54
, pp. 336-339
-
-
Modzelewski, R.A.1
Davies, P.2
Watkins, S.C.3
Auerbach, R.4
Chang, M.J.5
Johnson, C.S.6
-
10
-
-
0035819906
-
Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice
-
Beecken W.D., Fernandez A., Joussen A.M., Achilles E.G., Flynn E., Lo K.M., et al. Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. J Natl Cancer Inst 93 (2001) 382-387
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 382-387
-
-
Beecken, W.D.1
Fernandez, A.2
Joussen, A.M.3
Achilles, E.G.4
Flynn, E.5
Lo, K.M.6
-
11
-
-
17944370631
-
Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
-
Shaheen R.M., Ahmad S.A., Liu W., Reinmuth N., Jung Y.D., Tseng W.W., et al. Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer 85 (2001) 584-589
-
(2001)
Br J Cancer
, vol.85
, pp. 584-589
-
-
Shaheen, R.M.1
Ahmad, S.A.2
Liu, W.3
Reinmuth, N.4
Jung, Y.D.5
Tseng, W.W.6
-
12
-
-
0036570220
-
Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability
-
Liao F., Doody J.F., Overholser J., Finnerty B., Bassi R., Wu Y., et al. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res 62 (2002) 2567-2575
-
(2002)
Cancer Res
, vol.62
, pp. 2567-2575
-
-
Liao, F.1
Doody, J.F.2
Overholser, J.3
Finnerty, B.4
Bassi, R.5
Wu, Y.6
-
13
-
-
0032535999
-
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
-
Arap W., Pasqualini R., and Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279 (1998) 377-380
-
(1998)
Science
, vol.279
, pp. 377-380
-
-
Arap, W.1
Pasqualini, R.2
Ruoslahti, E.3
-
14
-
-
0034125929
-
Current status of antiangiogenic factors
-
Talks K.L., and Harris A.L. Current status of antiangiogenic factors. Br J Haematol 109 (2000) 477-489
-
(2000)
Br J Haematol
, vol.109
, pp. 477-489
-
-
Talks, K.L.1
Harris, A.L.2
-
15
-
-
0037106374
-
Mechanisms and future directions for angiogenesis-based cancer therapies
-
Scappaticci F.A. Mechanisms and future directions for angiogenesis-based cancer therapies. J Clin Oncol 20 (2002) 3906-3927
-
(2002)
J Clin Oncol
, vol.20
, pp. 3906-3927
-
-
Scappaticci, F.A.1
-
16
-
-
10344220521
-
Endogenous angiogenesis inhibitors
-
Folkman J. Endogenous angiogenesis inhibitors. APMIS 112 (2004) 496-507
-
(2004)
APMIS
, vol.112
, pp. 496-507
-
-
Folkman, J.1
-
17
-
-
13244291424
-
Angiogenesis inhibitors in the treatment of colorectal cancer
-
Iqbal S., and Lenz H.J. Angiogenesis inhibitors in the treatment of colorectal cancer. Semin Oncol 31 (2004) 10-16
-
(2004)
Semin Oncol
, vol.31
, pp. 10-16
-
-
Iqbal, S.1
Lenz, H.J.2
-
18
-
-
2442621619
-
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
-
Ferrara N., Hillan K.J., Gerber H.P., and Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3 (2004) 391-400
-
(2004)
Nat Rev Drug Discov
, vol.3
, pp. 391-400
-
-
Ferrara, N.1
Hillan, K.J.2
Gerber, H.P.3
Novotny, W.4
-
19
-
-
0033782775
-
Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
-
Wei Y.Q., Wang Q.R., Zhao X., Yang L., Tian L., Lu Y., et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med 6 (2000) 1160-1166
-
(2000)
Nat Med
, vol.6
, pp. 1160-1166
-
-
Wei, Y.Q.1
Wang, Q.R.2
Zhao, X.3
Yang, L.4
Tian, L.5
Lu, Y.6
-
20
-
-
10744233056
-
Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity
-
Okaji Y., Tsuno N.H., Kitayama J., Saito S., Takahashi T., Kawai K., et al. Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity. Cancer Sci 95 (2004) 85-90
-
(2004)
Cancer Sci
, vol.95
, pp. 85-90
-
-
Okaji, Y.1
Tsuno, N.H.2
Kitayama, J.3
Saito, S.4
Takahashi, T.5
Kawai, K.6
-
21
-
-
0032867645
-
Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101
-
Murakami K., Sakukawa R., Sano M., Hashimoto A., Shibata J., Yamada Y., et al. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101. Clin Cancer Res 5 (1999) 2304-2310
-
(1999)
Clin Cancer Res
, vol.5
, pp. 2304-2310
-
-
Murakami, K.1
Sakukawa, R.2
Sano, M.3
Hashimoto, A.4
Shibata, J.5
Yamada, Y.6
-
22
-
-
0033912198
-
Angiogenesis of liver metastases: role of sinusoidal endothelial cells
-
Gervaz P., Scholl B., Mainguene C., Poitry S., Gillet M., and Wexner S. Angiogenesis of liver metastases: role of sinusoidal endothelial cells. Dis Colon Rectum 43 (2000) 980-986
-
(2000)
Dis Colon Rectum
, vol.43
, pp. 980-986
-
-
Gervaz, P.1
Scholl, B.2
Mainguene, C.3
Poitry, S.4
Gillet, M.5
Wexner, S.6
-
23
-
-
0141996422
-
Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E
-
Shibuya M. Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E. Cancer Sci 94 (2003) 751-756
-
(2003)
Cancer Sci
, vol.94
, pp. 751-756
-
-
Shibuya, M.1
-
24
-
-
0041439704
-
Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2
-
Liu J.Y., Wei Y.Q., Yang L., Zhao X., Tian L., Hou J.M., et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood 102 (2003) 1815-1823
-
(2003)
Blood
, vol.102
, pp. 1815-1823
-
-
Liu, J.Y.1
Wei, Y.Q.2
Yang, L.3
Zhao, X.4
Tian, L.5
Hou, J.M.6
-
25
-
-
23944490634
-
Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities
-
Hou J.M., Liu J.Y., Yang L., Zhao X., Tian L., Ding Z.Y., et al. Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities. Oncology 69 (2005) 81-87
-
(2005)
Oncology
, vol.69
, pp. 81-87
-
-
Hou, J.M.1
Liu, J.Y.2
Yang, L.3
Zhao, X.4
Tian, L.5
Ding, Z.Y.6
-
26
-
-
0037124333
-
Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis
-
Li Y., Wang M.N., Li H., King K.D., Bassi R., Sun H., et al. Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis. J Exp Med 195 (2002) 1575-1584
-
(2002)
J Exp Med
, vol.195
, pp. 1575-1584
-
-
Li, Y.1
Wang, M.N.2
Li, H.3
King, K.D.4
Bassi, R.5
Sun, H.6
-
27
-
-
0036913333
-
A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth
-
Niethammer A.G., Xiang R., Becker J.C., Wodrich H., Pertl U., Karsten G., et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med 8 (2002) 1369-1375
-
(2002)
Nat Med
, vol.8
, pp. 1369-1375
-
-
Niethammer, A.G.1
Xiang, R.2
Becker, J.C.3
Wodrich, H.4
Pertl, U.5
Karsten, G.6
-
28
-
-
4043175386
-
A DNA vaccine against extracellular domains 1-3 of flk-1 and its immune preventive and therapeutic effects against H22 tumor cell in vivo
-
Lu F., Qin Z.Y., Yang W.B., Qi Y.X., and Li Y.M. A DNA vaccine against extracellular domains 1-3 of flk-1 and its immune preventive and therapeutic effects against H22 tumor cell in vivo. World J Gastroenterol 10 (2004) 2039-2044
-
(2004)
World J Gastroenterol
, vol.10
, pp. 2039-2044
-
-
Lu, F.1
Qin, Z.Y.2
Yang, W.B.3
Qi, Y.X.4
Li, Y.M.5
-
29
-
-
24744466525
-
T cell-mediated suppression of angiogenesis results in tumor protective immunity
-
Zhou H., Luo Y., Mizutani M., Mizutani N., Reisfeld R.A., and Xiang R. T cell-mediated suppression of angiogenesis results in tumor protective immunity. Blood 106 (2005) 2026-2032
-
(2005)
Blood
, vol.106
, pp. 2026-2032
-
-
Zhou, H.1
Luo, Y.2
Mizutani, M.3
Mizutani, N.4
Reisfeld, R.A.5
Xiang, R.6
-
30
-
-
19644378474
-
Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2
-
Wada S., Tsunoda T., Baba T., Primus F.J., Kuwano H., Shibuya M., et al. Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2. Cancer Res 65 (2005) 4939-4946
-
(2005)
Cancer Res
, vol.65
, pp. 4939-4946
-
-
Wada, S.1
Tsunoda, T.2
Baba, T.3
Primus, F.J.4
Kuwano, H.5
Shibuya, M.6
-
31
-
-
0035949593
-
Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen
-
Wei Y.Q., Huang M.J., Yang L., Zhao X., Tian L., Lu Y., et al. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci USA 98 (2001) 11545-11550
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 11545-11550
-
-
Wei, Y.Q.1
Huang, M.J.2
Yang, L.3
Zhao, X.4
Tian, L.5
Lu, Y.6
-
32
-
-
18144364350
-
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
-
Presta M., Dell'Era P., Mitola S., Moroni E., Ronca R., and Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16 (2005) 159-178
-
(2005)
Cytokine Growth Factor Rev
, vol.16
, pp. 159-178
-
-
Presta, M.1
Dell'Era, P.2
Mitola, S.3
Moroni, E.4
Ronca, R.5
Rusnati, M.6
-
33
-
-
0038498050
-
Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice
-
He Q.M., Wei Y.Q., Tian L., Zhao X., Su J.M., Yang L., et al. Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice. J Biol Chem 278 (2003) 21831-21836
-
(2003)
J Biol Chem
, vol.278
, pp. 21831-21836
-
-
He, Q.M.1
Wei, Y.Q.2
Tian, L.3
Zhao, X.4
Su, J.M.5
Yang, L.6
-
34
-
-
0034624074
-
Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development
-
Plum S.M., Holaday J.W., Ruiz A., Madsen J.W., Fogler W.E., and Fortier A.H. Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development. Vaccine 19 (2000) 1294-1303
-
(2000)
Vaccine
, vol.19
, pp. 1294-1303
-
-
Plum, S.M.1
Holaday, J.W.2
Ruiz, A.3
Madsen, J.W.4
Fogler, W.E.5
Fortier, A.H.6
-
35
-
-
1942487872
-
Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction
-
Plum S.M., Vu H.A., Mercer B., Fogler W.E., and Fortier A.H. Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction. Immunopharmacol Immunotoxicol 26 (2004) 29-41
-
(2004)
Immunopharmacol Immunotoxicol
, vol.26
, pp. 29-41
-
-
Plum, S.M.1
Vu, H.A.2
Mercer, B.3
Fogler, W.E.4
Fortier, A.H.5
-
36
-
-
13844250537
-
The epidermal growth factor receptor as a target for colorectal cancer therapy
-
Lockhart C., and Berlin J.D. The epidermal growth factor receptor as a target for colorectal cancer therapy. Semin Oncol 32 (2005) 52-60
-
(2005)
Semin Oncol
, vol.32
, pp. 52-60
-
-
Lockhart, C.1
Berlin, J.D.2
-
37
-
-
28044433677
-
Epidermal growth factor receptor and angiogenesis: opportunities for combined anticancer strategies
-
van Cruijsen H., Giaccone G., and Hoekman K. Epidermal growth factor receptor and angiogenesis: opportunities for combined anticancer strategies. Int J Cancer 117 (2005) 883-888
-
(2005)
Int J Cancer
, vol.117
, pp. 883-888
-
-
van Cruijsen, H.1
Giaccone, G.2
Hoekman, K.3
-
38
-
-
0036733591
-
Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas
-
Baker C.H., Kedar D., McCarty M.F., Tsan R., Weber K.L., Bucana C.D., et al. Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. Am J Pathol 161 (2002) 929-938
-
(2002)
Am J Pathol
, vol.161
, pp. 929-938
-
-
Baker, C.H.1
Kedar, D.2
McCarty, M.F.3
Tsan, R.4
Weber, K.L.5
Bucana, C.D.6
-
39
-
-
20944443737
-
Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor
-
Hu B., Wei Y., Tian L., Zhao X., Lu Y., Wu Y., et al. Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor. J Immunother 28 (2005) 236-244
-
(2005)
J Immunother
, vol.28
, pp. 236-244
-
-
Hu, B.1
Wei, Y.2
Tian, L.3
Zhao, X.4
Lu, Y.5
Wu, Y.6
-
40
-
-
4344652820
-
Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer
-
Fonsatti E., and Maio M. Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med 2 (2004) 18
-
(2004)
J Transl Med
, vol.2
, pp. 18
-
-
Fonsatti, E.1
Maio, M.2
-
41
-
-
4544236628
-
Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen
-
Tan G.H., Wei Y.Q., Tian L., Zhao X., Yang L., Li J., et al. Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen. Eur J Immunol 34 (2004) 2012-2021
-
(2004)
Eur J Immunol
, vol.34
, pp. 2012-2021
-
-
Tan, G.H.1
Wei, Y.Q.2
Tian, L.3
Zhao, X.4
Yang, L.5
Li, J.6
-
42
-
-
7044224626
-
Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities
-
Tan G.H., Tian L., Wei Y.Q., Zhao X., Li J., Wu Y., et al. Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities. Int J Cancer 112 (2004) 701-706
-
(2004)
Int J Cancer
, vol.112
, pp. 701-706
-
-
Tan, G.H.1
Tian, L.2
Wei, Y.Q.3
Zhao, X.4
Li, J.5
Wu, Y.6
-
43
-
-
0030764063
-
Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
-
Wong A.L., Haroon Z.A., Werner S., Dewhirst M.W., Greenberg C.S., and Peters K.G. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81 (1997) 567-574
-
(1997)
Circ Res
, vol.81
, pp. 567-574
-
-
Wong, A.L.1
Haroon, Z.A.2
Werner, S.3
Dewhirst, M.W.4
Greenberg, C.S.5
Peters, K.G.6
-
44
-
-
2342464166
-
Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2
-
Ramage J.M., Metheringham R., Conn A., Spendlove I., Moss R.S., Patton D.T., et al. Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. Int J Cancer 110 (2004) 245-250
-
(2004)
Int J Cancer
, vol.110
, pp. 245-250
-
-
Ramage, J.M.1
Metheringham, R.2
Conn, A.3
Spendlove, I.4
Moss, R.S.5
Patton, D.T.6
-
46
-
-
0036230027
-
Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3
-
Lou Y.Y., Wei Y.Q., Yang L., Zhao X., Tian L., Lu Y., et al. Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3. Immunol Invest 31 (2002) 51-69
-
(2002)
Immunol Invest
, vol.31
, pp. 51-69
-
-
Lou, Y.Y.1
Wei, Y.Q.2
Yang, L.3
Zhao, X.4
Tian, L.5
Lu, Y.6
-
47
-
-
0035678089
-
Identification of a novel membrane protein, HP59, with therapeutic potential as a target of tumor angiogenesis
-
Fu C., Bardhan S., Cetateanu N.D., Wamil B.D., Wang Y., Yan H.P., et al. Identification of a novel membrane protein, HP59, with therapeutic potential as a target of tumor angiogenesis. Clin Cancer Res 7 (2001) 4182-4194
-
(2001)
Clin Cancer Res
, vol.7
, pp. 4182-4194
-
-
Fu, C.1
Bardhan, S.2
Cetateanu, N.D.3
Wamil, B.D.4
Wang, Y.5
Yan, H.P.6
-
48
-
-
0034956272
-
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis
-
John A., and Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7 (2001) 14-23
-
(2001)
Pathol Oncol Res
, vol.7
, pp. 14-23
-
-
John, A.1
Tuszynski, G.2
-
49
-
-
0037308585
-
Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2
-
Su J.M., Wei Y.Q., Tian L., Zhao X., Yang L., He Q.M., et al. Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2. Cancer Res 63 (2003) 600-607
-
(2003)
Cancer Res
, vol.63
, pp. 600-607
-
-
Su, J.M.1
Wei, Y.Q.2
Tian, L.3
Zhao, X.4
Yang, L.5
He, Q.M.6
-
50
-
-
0037267333
-
Validating survivin as a cancer therapeutic target
-
Altieri D.C. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3 (2003) 46-54
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 46-54
-
-
Altieri, D.C.1
-
51
-
-
14944359615
-
Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant
-
Tu S.P., Cui J.T., Liston P., Huajiang X., Xu R., Lin M.C., et al. Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant. Gastroenterology 128 (2005) 361-375
-
(2005)
Gastroenterology
, vol.128
, pp. 361-375
-
-
Tu, S.P.1
Cui, J.T.2
Liston, P.3
Huajiang, X.4
Xu, R.5
Lin, M.C.6
-
52
-
-
12544259115
-
A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication
-
Xiang R., Mizutani N., Luo Y., Chiodoni C., Zhou H., Mizutani M., et al. A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res 65 (2005) 553-561
-
(2005)
Cancer Res
, vol.65
, pp. 553-561
-
-
Xiang, R.1
Mizutani, N.2
Luo, Y.3
Chiodoni, C.4
Zhou, H.5
Mizutani, M.6
-
53
-
-
0030746260
-
Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen
-
Foon K.A., John W.J., Chakraborty M., Sherratt A., Garrison J., Flett M., et al. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. Clin Cancer Res 3 (1997) 1267-1276
-
(1997)
Clin Cancer Res
, vol.3
, pp. 1267-1276
-
-
Foon, K.A.1
John, W.J.2
Chakraborty, M.3
Sherratt, A.4
Garrison, J.5
Flett, M.6
-
54
-
-
20244383301
-
Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules
-
Morse M.A., Clay T.M., Hobeika A.C., Osada T., Khan S., Chui S., et al. Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules. Clin Cancer Res 11 (2005) 3017-3024
-
(2005)
Clin Cancer Res
, vol.11
, pp. 3017-3024
-
-
Morse, M.A.1
Clay, T.M.2
Hobeika, A.C.3
Osada, T.4
Khan, S.5
Chui, S.6
-
55
-
-
3142692559
-
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
-
Yu J.S., Liu G., Ying H., Yong W.H., Black K.L., and Wheeler C.J. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 64 (2004) 4973-4979
-
(2004)
Cancer Res
, vol.64
, pp. 4973-4979
-
-
Yu, J.S.1
Liu, G.2
Ying, H.3
Yong, W.H.4
Black, K.L.5
Wheeler, C.J.6
-
56
-
-
0036342170
-
Immunological aspects of blood transfusions
-
Brand A. Immunological aspects of blood transfusions. Transpl Immunol 10 (2002) 183-190
-
(2002)
Transpl Immunol
, vol.10
, pp. 183-190
-
-
Brand, A.1
-
57
-
-
0026500945
-
Effect of allogeneic blood transfusion on solid tumor growth and pulmonary metastases in mice
-
Shirwadkar S., Blajchman M.A., Frame B., and Singal D.P. Effect of allogeneic blood transfusion on solid tumor growth and pulmonary metastases in mice. J Cancer Res Clin Oncol 118 (1992) 176-180
-
(1992)
J Cancer Res Clin Oncol
, vol.118
, pp. 176-180
-
-
Shirwadkar, S.1
Blajchman, M.A.2
Frame, B.3
Singal, D.P.4
-
58
-
-
0028110311
-
Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery
-
Heiss M.M., Mempel W., Delanoff C., Jauch K.W., Gabka C., Mempel M., et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 12 (1994) 1859-1867
-
(1994)
J Clin Oncol
, vol.12
, pp. 1859-1867
-
-
Heiss, M.M.1
Mempel, W.2
Delanoff, C.3
Jauch, K.W.4
Gabka, C.5
Mempel, M.6
-
59
-
-
13844312942
-
A novel method for isolation of endothelial cells and macrophages from murine tumors based on Ac-LDL uptake and CD16 expression
-
Okaji Y., Tsuno N.H., Kitayama J., Saito S., Takahashi T., Kawai K., et al. A novel method for isolation of endothelial cells and macrophages from murine tumors based on Ac-LDL uptake and CD16 expression. J Immunol Methods 295 (2004) 183-193
-
(2004)
J Immunol Methods
, vol.295
, pp. 183-193
-
-
Okaji, Y.1
Tsuno, N.H.2
Kitayama, J.3
Saito, S.4
Takahashi, T.5
Kawai, K.6
|